Garry McDowell

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Network Analysis

Mesenchymal Stem Cells

Atrial Fibrillation

Cognitive Impairment

Top Venues

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Riccardo Proietti, Jose Miguel Rivera-Caravaca, Raquel López-Gálvez, Stephanie L Harrison, Francisco Marín, Paula Underhill, Eduard Shantsila, Garry McDowell, Manlio Vinciguerra, Rhys Davies, Clarissa M Giebel, Deirdre A Lane, Gregory Yoke Hong Lip
Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis. Journal of clinical medicine 12 (8) (2023)
Riccardo Proietti, Jose Miguel Rivera-Caravaca, Raquel López-Gálvez, Stephanie L Harrison, Francisco Marín, Paula Underhill, Eduard Shantsila, Garry McDowell, Manlio Vinciguerra, Rhys Davies, Clarissa M Giebel, Deirdre A Lane, Gregory Yoke Hong Lip
Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis. Journal of clinical medicine 12 (8) (2023)
Riccardo Proietti, Jose Miguel Rivera-Caravaca, Raquel López-Gálvez, Stephanie L Harrison, Francisco Marín, Paula Underhill, Eduard Shantsila, Garry McDowell, Manlio Vinciguerra, Rhys Davies, Clarissa M Giebel, Deirdre A Lane, Gregory Yoke Hong Lip
Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis. Journal of clinical medicine 12 (8) (2023)
Riccardo Proietti, Jose Miguel Rivera-Caravaca, Raquel López-Gálvez, Stephanie L Harrison, Francisco Marín, Paula Underhill, Eduard Shantsila, Garry McDowell, Manlio Vinciguerra, Rhys Davies, Clarissa M Giebel, Deirdre A Lane, Gregory Yoke Hong Lip
Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis. Journal of clinical medicine 12 (8) (2023)